Immediate Impact

61 standout
Sub-graph 1 of 25

Citing Papers

Crohn's disease
2024 Standout
Navigating the complexities of drug development for inflammatory bowel disease
2024 Standout
5 intermediate papers

Works of Michael Wagner being referenced

Budesonide treatment of patients with collagenous colitis restores normal eosinophil and T-cell activity in the colon
2009
Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease
2008

Author Peers

Author Last Decade Papers Cites
Michael Wagner 143 88 59 141 133 26 418
Richard P. Harmel 204 14 15 34 29 27 469
Dawn Cooper 113 20 4 86 45 16 456
Edwin J. Smith 78 23 22 141 10 20 442
Valéry Blasco 128 51 18 109 12 17 404
Esther Mancebo 101 8 9 51 33 34 467
P. Peyronnet 75 5 55 64 21 19 402
Max Guillot 132 53 20 64 34 37 471
C. Leroux‐Robert 70 6 13 77 36 40 483
Zachary W. Fitch 189 31 14 50 36 35 377
Ashham Mansur 165 68 13 200 20 38 453

All Works

Loading papers...

Rankless by CCL
2026